Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for ...

The biosimilar product is a recombinant, humanized antibody Fab' fragment, with specificity for human tumor necrosis factor alpha (TNFα), conjugated to an approximately 40kDa polyethylene glycol.

Cytokine networks demonstrate dual functionality. Cytokines are key regulators of immune homeostasis, but paradoxically, cytokines also function as pathogenic drivers in diseases such as systemic ...

The drug is indicated for the treatment rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...

PRAGUE, July 9, 2025 /PRNewswire/ -- Zentiva Group and global pharmaceutical company Lupin Limited, have entered into a license and supply agreement for commercialization of Lupin's biosimilar ...

Think prolonged fasting reduces inflammation? This new review suggests it might do the opposite. Here's what the latest ...

Sesame seeds and sesame oil are rich in bioactive lignans, tocopherols, and unsaturated fatty acids that exert antioxidant, ...

As patients increasingly turn to cannabis for chronic pain, clinicians grapple with mixed evidence and a lack of high-quality ...

Lupin & Zentiva ink licensing and supply agreement for commercializing biosimilar Certolizumab Pegol: Our Bureau, Mumbai Wednesday, July 9, 2025, 16:20 Hrs [IST] Global Pharma maj ...

Pharma major Lupin has signed a USD 50 million agreement with a European pharmaceutical company. Lupin has entered into a license and supply agreement to commercialize its biosimilar Certolizumab ...